1-2 of 2
Sandeep Gurbuxani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks

Sriram Sundaravel, Wen-Liang Kuo, Jong Jin Jeong, Gaurav S. Choudhary, Shanisha Gordon-Mitchell, Hui Liu, Tushar D. Bhagat, Kathy L. McGraw, Sandeep Gurbuxani, Alan F. List, Amit Verma, Amittha Wickrema
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (18): 5638–5649.
https://doi.org/10.1158/1078-0432.CCR-19-0924
Published: 13 September 2019
View article titled, Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks
Open the PDF for Loss of Function of DOCK4 in Myelodysplastic Syndromes Stem Cells is Restored by Inhibitors of DOCK4 Signaling Networks in another window
Includes: Supplementary data
Journal Articles

Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial

Naseema Gangat, Christian Marinaccio, Ronan Swords, Justin M. Watts, Sandeep Gurbuxani, Alfred Rademaker, Angela J. Fought, Olga Frankfurt, Jessica K. Altman, Qiang Jeremy Wen, Noushin Farnoud, Christopher A. Famulare, Akshar Patel, Roberto Tapia, Rangit R. Vallapureddy, Stephanie Barath, Amy Graf, Amy Handlogten, Darci Zblewski, Mrinal M. Patnaik, Aref Al-kali, Yvonne Trang Dinh, Kristen Englund Prahl, Shradha Patel, Juan Carlos Nobrega, Dalissa Tejera, Amber Thomassen, Juehua Gao, Peng Ji, Raajit K. Rampal, Francis J. Giles, Ayalew Tefferi, Brady Stein, John D. Crispino
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (16): 4898–4906.
https://doi.org/10.1158/1078-0432.CCR-19-1005
Published: 15 August 2019
View article titled, Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial
Open the PDF for Aurora Kinase A Inhibition Provides Clinical Benefit, Normalizes Megakaryocytes, and Reduces Bone Marrow Fibrosis in Patients with Myelofibrosis: A Phase I Trial in another window
Includes: Supplementary data